HighTide Therapeutics Email Format

Pharmaceutical ManufacturingGuangdong, China11-50 Employees

HighTide Therapeutics, Inc. is a biopharmaceutical company based in Shenzhen, Guangdong, China, that develops multifunctional, multi-targeted therapies for chronic metabolic diseases with an emphasis on addressing residual risks of cardiovascular-kidney-metabolic syndrome. It operates in the pharmaceutical manufacturing industry and maintains a globally integrated pipeline of proprietary assets and multiple clinical programs across chronic metabolic diseases. The company’s lead asset, HTD1801, has received FDA Fast Track and Orphan Drug designations and has been selected for China's National Major Science and Technology Project for Significant New Drug Development. HighTide Therapeutics employs 11-50 people and maintains a website at https://hightidetx.com. The company went public in December 2023 on the Hong Kong Stock Exchange, trading under the ticker 2511.HK.

Sign up for free to view info

Company overview Employee directory